Journal Ranking

Unranked

Not Yet Ranked

Quality metrics need to be calculated to establish ranking.

Recent Activity

Page Views (30d) 21

Unique Visitors 21

Annals of hematology

Indexings	scopus ncbi ulakbim sci
Short Name	Ann Hematol
Abbreviated Name	ann hematol
ISSN	1432-0584
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (85 total)

2020

Phenotypic characterization of macrophages in the BMB sample of human acute leukemia.

Song, Jian-Xin;Wen, Yan;Li, Rui-Wei;Dong, Ting;Tang, Yi-Fei;Zhang, Juan-Juan;Sa, Ya-Lian;

348 views DOI Abstract

1970

DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells

P. J. Smith;C. Rackstraw;F. Cotter;P. J. Smith;C. Rackstraw;F. Cotter;

Vol. 69 , No. 1 , pp. S7-S11

287 views DOI Abstract

2020

Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.

Nicoletti, Eileen;Rao, Gayatri;Bueren, Juan A;Río, Paula;Navarro, Susana;Surrallés, Jordi;Choi, Grace;Schwartz, Jonathan D;

, pp. 0-0

286 views DOI Abstract

2005

Is splenectomy a contraindication for patients with myelodysplastic syndromes complicated by splenomegaly?

Ryo Uchida;Sonoko Nakano;Kyoko Namura;Noriko Yamada;Shin-ichi Fuchida;Akira Okano;Masashi Okamoto;Naoya Ochiai;Chihiro Shimazaki;Ryo Uchida;Sonoko Nakano;Kyoko Namura;Noriko Yamada;Shin-ichi Fuchida;Akira Okano;Masashi Okamoto;Naoya Ochiai;Chihiro Shimazaki;

Vol. 85 , No. 3 , pp. 198-199

286 views DOI

2006

Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study

Enrico Balleari;Edoardo Rossi;Marino Clavio;Angela Congiu;Marco Gobbi;Marco Grosso;Vincenzo Secondo;Mauro Spriano;Silvana Timitilli;Riccardo Ghio;Enrico Balleari;Edoardo Rossi;Marino Clavio;Angela Congiu;Marco Gobbi;Marco Grosso;Vincenzo Secondo;Mauro Spriano;Silvana Timitilli;Riccardo Ghio;

Vol. 85 , No. 3 , pp. 174-180

276 views DOI Abstract

2012

(Bortezomib plus lenalidomide/thalidomide)- vs (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials

Anyou Wang;Qiaohong Duan;Xin Liu;Kaiyang Ding;Yongsheng Han;Weibo Zhu;Xiaoyan Cai;Jingsheng Wu;Zimin Sun;Anyou Wang;Qiaohong Duan;Xin Liu;Kaiyang Ding;Yongsheng Han;Weibo Zhu;Xiaoyan Cai;Jingsheng Wu;Zimin Sun;

Vol. 91 , No. 11 , pp. 1779-1784

269 views DOI Abstract

1970

Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage

E. Jost;L. Michaux;M. Vanden Abeele;B. Boland;D. Latinne;C. Godfraind;J. Scheiff;J. Vaerman;F. Lecouvet;A. Ferrant;E. Jost;L. Michaux;M. Vanden Abeele;B. Boland;D. Latinne;C. Godfraind;J. Scheiff;J. Vaerman;F. Lecouvet;A. Ferrant;

Vol. 80 , No. 5 , pp. 302-307

265 views DOI Abstract

2017

Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios.

Saglio, Giuseppe;le Coutre, Philipp;Cortes, Jorge;Mayer, Jiří;Rowlings, Philip;Mahon, François-Xavier;Kroog, Glenn;Gooden, Kyna;Subar, Milayna;Shah, Neil P;

Vol. 96 , No. 8 , pp. 1303-1313

264 views DOI Abstract

1970

FAB classification of myelodysplastic syndromes: merits and controversies

G. E. G. Verhoef;S. Pittaluga;C. De Wolf-Peeters;M. A. Boogaerts;G. E. G. Verhoef;S. Pittaluga;C. De Wolf-Peeters;M. A. Boogaerts;

Vol. 71 , No. 1 , pp. 3-11

262 views DOI Abstract

2020

Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study.

Peffault de Latour, Régis;Huynh, Lynn;Ivanova, Jasmina I;Totev, Todor;Bilginsoy, Mehmet;Antin, Joseph;Roy, Anuja;Duh, Mei Sheng;

261 views DOI Abstract

View All 85 Articles

Overall

Not Rated

Journament